Company / Operating Cash Flow per Share
PLIANT THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.56
FY2025
5-year range
-$2.56 / -$0.08
FY2021-FY2025
Trend
-61.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-2.56 in FY2025 to $-0.08 in FY2021.
Based on SEC 10-K filings.
-2.56 in FY2025.
Declined from $-1.54 to $-2.56 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 61.8% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.56 | -61.8% |
| FY2024 | -$1.58 | -2.4% |
| FY2023 | -$1.54 | +26.3% |
| FY2022 | -$2.09 | -2603.0% |
| FY2021 | -$0.08 | +94.8% |
| FY2020 | -$1.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026